Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 23, 180-183, February 1, 1963]
© 1963 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sherman, J. D.
Right arrow Articles by Friedell, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sherman, J. D.
Right arrow Articles by Friedell, G. H.

The Treatment of Anemia in the Tumor-bearing Hamster with Cortisone and Sodium Salicylate*

Joseph D. Sherman{dagger} and Gilbert H. Friedell{ddagger}

( Department of Pathology, Massachusetts Memorial Hospitals, Boston, Massachusetts)

Both cortisone acetate and sodium salicylate administered from the time of, or 1 week after, tumor transplantation inhibited the growth of a transplantable fibrosarcoma. Hamsters in these two treatment groups did not develop the anemia and splenomegaly which characteristically accompany the growth of this tumor in untreated animals. Their failure to develop anemia was attributed primarily to inhibition of tumor growth.

In anemic hamsters bearing large, advanced fibrosarcomas, however, the administration of cortisone prevented profound splenic changes and restored the hemoglobin to normal levels. Tumor necrosis was increased somewhat in these animals, but the abnormal splenic hemolysis produced by the necrotic tissue was thought to have been inhibited by the cortisone. Sodium salicylate was of transient therapeutic benefit in correcting the hemolytic anemia of the tumor-bearing hamster, and the morphology of the spleen was less abnormal than in the untreated tumor-bearing animal.

* This work was supported in part by grant No. C-4959 from the National Institutes of Health, National Cancer Institute of the U.S. Public Health Service.

{dagger} Present address: Blood Research Laboratory, Pratt Clinic-New England Center Hospital, Boston, Mass. Under tenure of USPHS Fellowship CF-3237.

{ddagger} Present address: Cancer Research Institute, New England Deaconess Hospital, Boston, Mass.

Received 5/31/62.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1963 by the American Association for Cancer Research.